Jalen Suggs
26-27 Projection
STL: league rank #9, top 10 in the league.
ORL
Has been available for roughly 65% of games across recent seasons, which pulls the games projection down.
Value
+4.04
League Leader2.3
This Player1.8
League Average0.8
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 21-22 | #295 |
| 22-23 | #196 |
| 23-24 | #114 |
| 24-25 | #85 |
| 25-26 | #53 |
| 26-27 Projection | #72 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 21-22 | 11.8 |
| 22-23 | 9.9 |
| 23-24 | 12.6 |
| 24-25 | 16.2 |
| 25-26 | 13.8 |
| 26-27 Projection | 13.7 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)NBA playoffs (aggregate — not in averages or ranks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 11.3 |
| Nov 2025 | 14.5 |
| Dec 2025 | 18.6 |
| Jan 2026 | 10.8 |
| Feb 2026 | 10.9 |
| Mar 2026 | 14.3 |
| Apr 2026 | 13.6 |
| Playoffs (playoffs) | 11.1 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
ORL — all five positions, best player first at each spot.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 26 | ORL | 53 | 0 | 27.4 | #72 | 4.04 | 13.7 | 3.6 | 4.4 | 1.6 | 0.7 | 2.1 | 43.3% | 11.3 | 85.1% | 2.3 | 2.4 |
| 25-26 | 25 | ORL | 57 | 0 | 27.6 | #53 | 4.32 | 13.8 | 3.9 | 5.5 | 1.8 | 0.7 | 2.1 | 43.5% | 11.4 | 85.5% | 2.1 | 2.7 |
| 24-25 | 24 | ORL | 35 | 0 | 28.6 | #85 | 3.32 | 16.2 | 4 | 3.7 | 1.5 | 0.9 | 2.2 | 41.0% | 13.7 | 88.2% | 3.1 | 2.9 |
| 23-24 | 23 | ORL | 75 | 0 | 27 | #114 | 2.13 | 12.6 | 3.1 | 2.7 | 1.4 | 0.6 | 2 | 47.1% | 9.5 | 75.6% | 2.1 | 1.8 |
| 22-23 | 22 | ORL | 53 | 0 | 23.5 | #196 | -0.44 | 9.9 | 3 | 2.9 | 1.3 | 0.5 | 1.2 | 41.9% | 8.4 | 72.3% | 2.2 | 1.8 |
| 21-22 | 21 | ORL | 48 | 0 | 27.2 | #295 | -2.27 | 11.8 | 3.6 | 4.4 | 1.2 | 0.4 | 0.9 | 36.1% | 11.4 | 77.3% | 3.4 | 3 |